抑制CHK2和DNA复制对癌细胞生长的协同作用
Flavie Coquel1,2, Sing-Zong Ho3, Keng-Chang Tsai4,5
1Institut de Génétique Humaine, Univ. de Montpellier, CNRS, Montpellier, France.
eLife
|January 31, 2025
概括
两种天然化合物,Psoralea corylifolia中的bakukiol和isobavachalcone,通过向DNA复制和修复途径,协同抑制癌细胞的增殖. 这种组合提供了一个有前途的,可能更好地容忍的抗癌疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞表现出高的复制压力 (RS),并依赖于DNA损伤检查点的生存.
- 目前针对RS或检查点的癌症疗法已显示出有效性,但也有严重的不良影响.
- 需要新的治疗策略来提高抗癌疗效,同时尽量减少毒性.
研究的目的:
- 通过选植物提取物来识别新型,耐受良好的抗癌药物.
- 研究天然化合物对癌细胞增殖的协同作用.
- 阐明已识别的化合物的抗癌活性背后的分子机制.
主要方法:
- 对植物提取物进行查,以检测是否有抑制癌细胞增殖的化合物.
- 生物化学试验,以确定巴库奇醇和异巴瓦哈尔对DNA复制和修复的影响.
- 在小鼠体内增殖试验和体内瘤异种移植研究.
主要成果:
- 确定了两种化合物,分别是来自Psoralea corylifolia的bakukiol和isobavachalcone.
- 巴库基醇抑制了DNA复制和激活CHK1; 异巴瓦哈尔抑制了DNA双链断裂修复和CHK2.2.
- 该组合在体外协同抑制了癌细胞的增殖,并在体内阻止了瘤的生长.
结论:
- 巴库奇醇和异巴瓦哈尔科尼的组合代表了一种新的协同作用的抗癌策略.
- 针对DNA复制和CHK2信号,利用了癌细胞的一个关键漏洞.
- 这种方法可能会导致开发改进的组合疗法,并减少不良影响.
相关概念视频
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:38S-Cdk Initiates DNA Replication
4.6K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.6K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K